04.11.2021 • News

Nouryon Expands US Levasil Capacity

Nouryon has announced plans to expand capacity for its Levasil colloidal silica at its site in Green Bay, Wisconsin, USA. The expansion will meet rising demand from North America’s construction and packaging sectors. Construction on the facilityis expected to be completed in the second half of 2022.

Patrick Wilhelm, vice president of inorganic specialties, said large governmental infrastructure projects are fueling the demand growth in construction while e-commerce is driving higher demand for packaging materials.

In construction applications, Levasil products provide durability to structures such as bridges and buildings. They are also used to create anti-slip surfaces in packaging applications, making stacking and handling of finished products easier and more efficient.

Nouryon has eight Levasil production plants around the world. It said expansions were ongoing in Sweden and Taiwan, but did not provide further details.

Author: Elaine Burridge, Freelance Journalist

Nouryon has announced plans to expand capacity for its Levasil colloidal silica...
Nouryon has announced plans to expand capacity for its Levasil colloidal silica at its site in Green Bay, Wisconsin, USA. The expansion will meet rising demand from North America’s construction and packaging sectors. Construction should be completed in H2 2022. (c) Nouryon

Company

Logo:

Nouryon

Christian Neefestraat 2
1077 WW Amsterdam
Netherlands

Company contact







Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.